The short version: mostly true, the marketing is shading it slightly cleaner than it actually is, and the most useful clinical move with Wellbutrin in…
Sections
- The actual numbers, because the marketing rounds them down
- How it works, in plain language
- The way it actually gets used most of the time
- What’s nice to hear about it
- Wellbutrin by itself
- Dosing
- Side effects in the order they actually come up
- Who shouldn’t take it
- The pattern that ends up on it
- What not to do
- How it stacks against the SSRIs
- Bottom line
- Sources
The short version: mostly true, the marketing is shading it slightly cleaner than it actually is, and the most useful clinical move with Wellbutrin in 2026 isn’t usually starting it by itself, it’s adding a small dose to an SSRI that’s working for the depression but tanked the sex life. That’s the move that earns its keep most of the time.
Wellbutrin (bupropion) is structurally and pharmacologically the odd one out in the antidepressant cabinet… it doesn’t touch serotonin, it works on norepinephrine and dopamine instead, which is the wiring most SSRIs leave alone. The SSRIs do the sexual side effects mostly through serotonin, so a drug that skips serotonin skips most of the sexual side effects. That’s the mechanistic argument and it mostly holds up. With some asterisks.
The actual numbers, because the marketing rounds them down
The pooled trial data and the head-to-head studies put the rate of sexual dysfunction on bupropion somewhere between five and fifteen percent depending on the study and what they were measuring. SSRIs are typically thirty to fifty percent in the same studies, and the real-world numbers when patients actually answer the question honestly are higher than the trial numbers because guys in clinical trials are answering intake questionnaires about their sex lives the way you’d answer intake questionnaires about your sex life, which is to say they’re not exactly competing for accuracy.
So Wellbutrin isn’t zero. It’s substantially lower than the SSRIs but not perfectly clean. About one in ten guys is going to notice something. A smaller fraction is going to notice enough to do something about it. That’s the honest number, and the gap between “the marketing says zero side effects” and “one in ten guys is going to feel something” is the part the marketing decided to round off.
How it works, in plain language
It bumps norepinephrine and dopamine availability up a little, by blocking the transporters that would normally clean those neurotransmitters back out of the synapse. Dopamine is the part that matters for libido… dopamine is what runs motivation, drive, the want-to-do-the-thing system, and a drug that nudges dopamine up tends to nudge libido up too, or at least doesn’t drag it down the way SSRIs do.
It’s also the only mainstream antidepressant that’s actually stimulating instead of sedating. Most guys take it in the morning. I tell patients to think of it as closer to a cup of coffee than to a sleeping pill, which is also why it’s FDA-approved for smoking cessation under the name Zyban (which is just Wellbutrin in a different costume, marketed for a different indication) and why it gets used off-label for the fatigue piece of depression that SSRIs don’t really hit.
The way it actually gets used most of the time
The workhorse move with Wellbutrin in current practice isn’t to start it alone, it’s to add 150 mg of Wellbutrin XL in the morning to a guy who’s already on an SSRI that’s working on the depression but who can’t reliably finish having sex with his wife anymore. The combination works because the bupropion is partially offsetting the serotonin-driven dampening of dopamine in the sexual response, while leaving the SSRI’s antidepressant effect intact. Two drugs, two different mechanisms, and the second one is patching the hole the first one made.
Probably half the guys on SSRIs around me end up on a low dose of Wellbutrin on top, specifically for this. It’s well-tolerated, it works for a substantial fraction of patients with this complaint, and the bonus is a little extra energy and motivation which usually helps the residual fatigue piece the SSRI didn’t fully clear. The bonus is real, it’s just not the main reason… it’s a side benefit that comes with the package.
What’s nice to hear about it
Most of the time I’m writing about an antidepressant I open with the risks because that’s the part patients don’t get told, but it’s worth flipping the order for this one. The relief Wellbutrin brings when it’s added to an SSRI that wrecked somebody’s sex life is genuinely a big deal. Guys come back six weeks after we added it and the conversation is some version of, oh, hey, that thing came back. The marriage gets a piece of itself returned. The half-conversation he was avoiding having with his wife is no longer one he’s avoiding. The wife notices. He notices that she noticed. That’s a real outcome that doesn’t show up on the rating scale but shows up in the appointment, and it’s worth saying out loud that this drug is genuinely useful at exactly that job.
Also, and this is a smaller thing but a real one, it usually doesn’t cause weight gain. Most antidepressants are a slow weight-up. Wellbutrin trends the other direction… not dramatically, three to seven pounds over a year in the trial data, but the direction is the right direction, which is unusual in this drug class.

Wellbutrin by itself
It works on its own for depression too, particularly the kind that’s mostly fatigue, low motivation, and anhedonia (the can’t-enjoy-things-you-used-to flavor) rather than the sad-and-anxious flavor. For depression that’s tangled up with ADHD, or for atypical depression, or for melancholic depression, Wellbutrin monotherapy is a real first-line option.
Where it doesn’t work well is in patients whose depression has a heavy anxiety component. Bupropion is activating, and for an already-anxious patient that activation can make the anxiety meaningfully worse. If the depression is mostly anxiety-flavored, Wellbutrin is not your first move… Lexapro or sertraline, both of which actually take the edge off anxiety, is the better starting point, and Wellbutrin can come in later if you need the dopamine effect on top.
Dosing
Comes as IR (immediate release, 75 or 100 mg, taken two to three times a day), SR (sustained release, 100 or 150 mg, twice daily), and XL (extended release, 150 or 300 mg, once a day in the morning). XL is what almost everybody’s on. Start at 150 mg XL in the morning, go up to 300 mg XL after a week or two if needed. Some patients end up at 450 mg, which is the max approved daily dose and which gets split as 300 mg in the morning plus a 150 mg around noon.
Don’t take it in the evening. The activation will keep you up.
Side effects in the order they actually come up
Insomnia is the first one, mostly if you took it too late in the day, fixed by moving the dose earlier… dry mouth is the second one, annoying but most guys tolerate it without complaint… a slightly jittery, almost stimulant-like feeling in the first week or two is the third one, usually clears on its own, if it doesn’t the dose may need to come down… anxiety can spike in people who came in with an anxiety component, which is usually the signal that this wasn’t the right drug for that patient… headache happens, comes and goes… modest weight loss, usually three to seven pounds, sometimes the other direction, the average trend in trials is down which is the opposite of what most antidepressants do.
Seizure risk is the one that actually matters. Bupropion lowers the seizure threshold, and at higher doses or in patients with predisposing factors it can cause seizures. The clinically relevant risk is in patients with eating disorders (especially anorexia or bulimia where the electrolyte issues compound the threshold drop), patients with a seizure history of their own, patients with significant head injury, and patients on other drugs that also lower the threshold. In a typical patient on a standard dose with none of those risk factors, the seizure risk is around one in a thousand at standard doses, higher at the 450 max.

Who shouldn’t take it
Patients with seizure disorders. Patients with active eating disorders. Patients with significant head trauma history. Patients on MAOIs (older antidepressants, see the Lexapro post for the MAOI digression). Patients with significant anxiety as the main presentation, where it’s likely to make things worse.
The pattern that ends up on it
Say you’ve got a guy who ends up on Wellbutrin-plus-an-SSRI — picture the one who came in a year ago looking like garbage, got put on sertraline at a real dose, climbed out of the depression hole over six to eight weeks, and then six months later showed up at the follow-up sheepishly mentioning that the sex with his wife had basically stopped because it had stopped being something his body could finish. He’d been waiting to bring it up because he didn’t want to seem ungrateful that the depression was better. I asked, and once asked he told me, and we added 150 mg of Wellbutrin in the morning, and six weeks after that the orgasm-timing thing was back in normal territory, the libido was back, the depression was still under control. Two years later he’s still on the combo. That’s the pattern. The depression treatment didn’t get switched out, just supplemented.
About one in ten guys is still going to notice something. The marketing rounded that down to zero.

What not to do
Don’t combine with a known seizure trigger like a big slug of caffeine right after a missed dose. Don’t combine with MAOIs. Don’t take it at bedtime, you’re not going to sleep. Don’t push the dose past 300 mg without a real reason, the dose-response above that flattens out and the seizure curve doesn’t.
Don’t expect it to do much for anxiety. If anxiety is the main thing for you, this is not the drug, even if your spouse just sent you a TikTok about how Wellbutrin doesn’t wreck your sex life. The TikTok is technically right about the sex but wrong about the use case.
Don’t drink heavily on it. Bupropion already lowers the seizure threshold, and alcohol withdrawal (which can happen even from moderate daily drinking, not just full-on alcoholism) lowers it more. The stack is a worse seizure risk than either piece on its own, and you don’t want the version of yourself who finds out about that from personal experience.
How it stacks against the SSRIs
Lexapro and sertraline are the SSRI workhorses, see the Lexapro post for that whole conversation. Wellbutrin sits next to them as the dopaminergic option for the same general patient population, used either as monotherapy in the right kind of depression (low energy, low motivation, no big anxiety component) or as the add-on for the SSRI sexual side effects. Both moves are valid. The marketing wants you to think of Wellbutrin as a category of its own, and it kind of is, but in practice it’s most often used in combination with one of the SSRIs rather than as a standalone antidepressant.
Bottom line
The reputation on the sexual side effect front is mostly accurate, the marketing rounds the one-in-ten guys down to zero which is the part to be honest about, the most common useful move is adding it to an SSRI rather than starting it alone, and the seizure risk is real but manageable in patients without specific risk factors. It’s one of the drugs I reach for the most, particularly in combination with SSRIs, for exactly the reason the marketing implies and then some. And if your prescriber acts surprised when you bring up the sexual side effects and doesn’t mention Wellbutrin as an option, your prescriber is reading the wrong magazine.
Sources
- Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC. Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. J Clin Psychiatry. 2001;62(3):185-90. PMID 11305705.
- Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 2004;65(1):62-7. PMID 14744170.
- Clayton AH, Pradko JF, Croft HA, et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry. 2002;63(4):357-66. PMID 12000211.
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-1366. PMID 29477251.